Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 49 | ECE2017 | Next issue

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

Card image cap
20-23 May 2017, Lisbon, Portugal Further information

Eposter Presentations: Diabetes, Obesity and Metabolism

Diabetes therapy

Previous section
Diabetes complications
Table of contents
Next section
Endocrine Disruptors

ea0049ep579 | Diabetes therapy

A modelling approach for cost-savings in the elderly ontarian population with type 2 diabetes due to reduction in mild hypoglycemia events for SGLT-2 inhibitor versus sulfonylurea (SU) initiation after metformin

ea0049ep580 | Diabetes therapy

Do adding B vitamins and folate to metformin has beneficial effect on renal function and lipids in type 2 diabetic patients

ea0049ep581 | Diabetes therapy

The role of sodium-glucose co-transporter 2 inhibitors as add-on therapy in type 2 diabetes

ea0049ep582 | Diabetes therapy

Abstract unavailable

ea0049ep583 | Diabetes therapy

Hypoglycemia, weight changes and health related quality of life (HRQoL) instruments for diabetes care

ea0049ep584 | Diabetes therapy

Use of an innovative Technology Enabled Care service (TECS) ‘Florence’ to empower patients and enhance adherence to BP treatments in diabetes

ea0049ep585 | Diabetes therapy

The decreased adiponectin level after the treatment with glibenclamide is associated with deterioration of left ventricular function

ea0049ep586 | Diabetes therapy

Effects of inositol on glucose homeostasis: systematic review and meta-analysis of randomized controlled trials

ea0049ep587 | Diabetes therapy

A rare pediatric presentation of type 1 diabetes mellitus with duchenne muscular dystrophy - what to expect in the future?

ea0049ep588 | Diabetes therapy

Significant effect of a group education program on glycemic control and incidence of hypoglycemia in patients with diabetes mellitus type 1: A case-controlled study

ea0049ep589 | Diabetes therapy

Dapagliflozin induced vulvovaginitis in an atopic patient with type 2 diabetes mellitus

ea0049ep590 | Diabetes therapy

Efficacy of body weight reduction on SGLT-2 inhibitor in people with type 2 diabetes mellitus

ea0049ep591 | Diabetes therapy

Modification of lifestyle and influence on leptin and insulin resistance to prevent type 2 diabetes mellitus

ea0049ep592 | Diabetes therapy

Australian women with diabetes survey of contraceptive use and beliefs about safety of contraceptive options

ea0049ep593 | Diabetes therapy

Management and control of hospital hyperglycemia in the health area of cuenca (Spain)

ea0049ep594 | Diabetes therapy

Impact of the insulin pump therapy on quality of life children and adolescents with diabetes mellitus type 1

ea0049ep595 | Diabetes therapy

Efficacy of insulin detemir treatment in type 2 diabetes mellitus is associated with a allele od the catechol o-methyltransferase polymorphism

ea0049ep596 | Diabetes therapy

A dramatic improvement in metabolic parameters and cutaneous manifestations of insulin-resistance in a type 2 diabetic patient with Congenital Generalized Lipodystrophy (Berardinelli-Seip Syndrome) treated with pioglitazone

ea0049ep597 | Diabetes therapy

Comparison of neonatal outcome in women with gestational diabetes on different pharmacoglogical agents dilevered at term

ea0049ep598 | Diabetes therapy

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

ea0049ep599 | Diabetes therapy

Pancreas transplantation: experience in a central hospital

ea0049ep600 | Diabetes therapy

Correlates of health-related quality of life in Bulgarian patients with type 2 diabetes mellitus

ea0049ep601 | Diabetes therapy

Effects of sitagliptin monotherapy on insulin resistance and immune functions in type 2 diabetic patients

ea0049ep602 | Diabetes therapy

Real practice experience: Degludec vs Glargina U300

ea0049ep603 | Diabetes therapy

Glycemic control and weight evolution in DM2 patients with canaglifozina

ea0049ep604 | Diabetes therapy

Intralesional epidermal growth factor treatment on diabetic foot ulcers

ea0049ep605 | Diabetes therapy

Efficacy and safety of evoglipitin monotherapy in patients with type 2 diabetes

ea0049ep606 | Diabetes therapy

Rabson mendenhall syndrome-a dilemma to treat in a resource poor country

ea0049ep607 | Diabetes therapy

Does tolerance develop toward GLP-1 receptor agonists’ glucose-lowering effect?

ea0049ep608 | Diabetes therapy

Comparative evaluation the effects of bariatric surgery and exenatide treatment on the clinical and laboratory parameters in obese type 2 diabetic patients

ea0049ep609 | Diabetes therapy

Increase in time in target when using a basal-bolus algorithm for insulin dosing with insulin glargine U300 during hospital stay

ea0049ep610 | Diabetes therapy

Intensity of dapagliflozin induced glycosuria correlates with previous glycemic control but not with body weight or duration of type 2 diabetes

ea0049ep611 | Diabetes therapy

How can dapagliflozin affect blood pressure response in a real-life cohort of people with type 2 diabetes and hypertension?

ea0049ep612 | Diabetes therapy

Trends in prescription of Sodium-glucose co-transporter-2 inhibitors (SGLT2i) over the last three years in a specialized setting

ea0049ep613 | Diabetes therapy

The insulin delivery system and its impact on quality of life and on psychopathological symptomatology

ea0049ep614 | Diabetes therapy

New long-acting insulins in type 1 diabetes: implications for real clinical practice

ea0049ep615 | Diabetes therapy

Effect of oral nitrate administration on glucose metabolism and inflammation in obese type 2 diabetic rats

ea0049ep616 | Diabetes therapy

Impact of a universal educational animation movie in an hour workshop on the knowledge of patients with gestational diabetes

ea0049ep617 | Diabetes therapy

Insulin requirements in pregnant women with DM 1 with different duration of the disease

ea0049ep618 | Diabetes therapy

Liraglutide restores the hyperglycemia-induced endothelial oxidative stress in vitro

ea0049ep619 | Diabetes therapy

Incretin-based therapies and pancreatic/biliary tract cancer

ea0049ep620 | Diabetes therapy

Palpable purpura in an uncontrolled diabetic patient: an uncommon possible side effect of linagliptin

ea0049ep621 | Diabetes therapy

Dulaglutide added on Empagliflozin improves blood pressure, body weight, glycemic control and albuminuria in obese diabetic patients

ea0049ep622 | Diabetes therapy

Modern treatment approaches of patients with type 2 diabetes and non-alcoholic fatty liver disease

ea0049ep623 | Diabetes therapy

The role of diabetic educational programs in glycemic control in patients attending to our day hospital

ea0049ep624 | Diabetes therapy

Real-time detection of hazardous changes in blood glucose at the first trimester of pregnancy in women with type 1 diabetes: a pilot study

ea0049ep625 | Diabetes therapy

Sense of coherence and glycaemic control among a sample of newly diagnosed type II diabetics in rural Crete

ea0049ep626 | Diabetes therapy

Gestacional diabetes mellitus with and without insulin therapy: a case study

ea0049ep627 | Diabetes therapy

Evaluation and descriptive analysis of our type 1 diabetes population and their insulin therapy

ea0049ep628 | Diabetes therapy

Effects of dapagliflozin in treatment of gastroparesis considering the state of carbohydrate metabolism in patients with type 2 diabetes mellitus

ea0049ep629 | Diabetes therapy

Self-monitoring of blood glucose: how are glycemic readers used in practice?

ea0049ep630 | Diabetes therapy

Determinants of patient’s adherence and its relation to therapeutic success after hospital admission for decompensated diabetes

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more